COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.
The Veterinary Oncology Market report points out national and global business prospects and competitive conditions for veterinary oncology. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for veterinary oncology. The veterinary oncology market has been segmented by animal type (companion animal (equine, canine, and feline), and livestock animal), by therapy type (chemotherapy, combination therapy, immunotherapy, and targeted therapy), by mode of administration (oral and intravenous), by application (canine lymphoma, osteosarcoma (osa), mast cell cancer, melanoma, and multiple myeloma), by distribution channel (hospital pharmacies, government agencies, and retail pharmacies). Historical background for the demand of veterinary oncology has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand veterinary oncology have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Market Segmentation:
By Animal Type:
By Therapy Type:
By Mode of Administration:
By Application:
By Distribution Channel:
By Region:
North America Veterinary Oncology Market
Europe Veterinary Oncology Market
Asia Pacific Veterinary Oncology Market
Middle East & Africa Veterinary Oncology Market
South America Veterinary Oncology Market
Major Companies: Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.
Years Covered in the Study:
Historic Year: 2017-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year: 2028
Objectives of this report:
Reasons to Buy This Report:
Customization:
This study is customized to meet your specific requirements:
For more information, contact: [email protected]
Single User (PDF)
3850Multi User (PDF)
5150Enterprise User (PDF)
7650Avail customized purchase options to meet your exact research needs.
Detailed scope covering all the major segments in the market
In line data validations to ensure data precision
Market recommendations supporting decision making processes
Round the clock analyst support to resolve your queries
Up to 15% additional free customization to meet your specific requirements